ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
Retail Trade

Sugi Holdings Co., Ltd.

Business Summary

Sugi Holdings Co., Ltd. engages in the management of its group companies which provides the management of the drug stores and dispensing business. The company provides the sale of medicines, health foods, cosmetics, daily necessities and prescription preparations, as well as the operation of local healthcare compliant drug store that tackles home healthcare in cooperation with regional medical personnel. It also operates visiting nursing stations that closely cooperate with regional medical institutions and social welfare operators, through the provision of visiting nursing services and in-home nursing care support services. The company was founded in December 1976 and is headquartered in Obu, Japan.

Financial Highlights

Feb 2022 JPYUSD
Revenue625,477M5,609.66M
Gross Profit191,490M1,717.40M
Operating income32,137M288.22M
Income before tax27,456M246.24M
Net income19,389M173.89M
EBITDA43,405M389.28M
Diluted EPS313.662.81
Dividends Per Share800.71
Total Assets336,380M2,920.59M
Total liabilities122,488M1,063.49M
Total equity213,890M1,857.08M
Operating cash flow7,174M64.34M
Currency in JPYCurrency in USD

Historical Data

 Feb 2018Feb 2019Feb 2020Feb 2021Feb 2022
Revenue 457,047M 488,464M 541,964M 602,850M 625,477M
Gross Profit 131,566M 142,300M 162,182M 181,631M 191,490M
Operating income 24,762M 25,817M 29,762M 34,041M 32,137M
Income before tax 24,559M 26,053M 29,926M 31,521M 27,456M
Net income 16,411M 17,940M 20,782M 21,120M 19,389M
EBITDA 31,217M 33,206M 38,174M 43,981M 43,405M
Diluted EPS 259.19 287.73 336.20 341.67 313.66
Dividends Per Share 60 70 80 80 80
Total Assets 254,934M 266,529M 314,905M 347,977M 336,380M
Total liabilities 92,886M 99,964M 132,153M 147,346M 122,488M
Total equity 162,046M 166,563M 182,750M 200,629M 213,890M
Operating cash flow 27,562M 22,894M 45,353M 34,027M 7,174M
 Feb 2018Feb 2019Feb 2020Feb 2021Feb 2022
Revenue 4,102.53M 4,421.30M 4,971.69M 5,689.35M 5,609.66M
Gross Profit 1,180.96M 1,288.02M 1,487.77M 1,714.13M 1,717.40M
Operating income 222.26M 233.68M 273.02M 321.25M 288.22M
Income before tax 220.44M 235.81M 274.52M 297.47M 246.24M
Net income 147.30M 162.38M 190.64M 199.31M 173.89M
EBITDA 280.20M 300.56M 350.18M 415.06M 389.28M
Diluted EPS 2.32 2.60 3.08 3.22 2.81
Dividends Per Share 0.53 0.63 0.73 0.75 0.71
Total Assets 2,389.14M 2,394.25M 2,919.43M 3,266.16M 2,920.59M
Total liabilities 870.49M 897.98M 1,225.17M 1,383.01M 1,063.49M
Total equity 1,518.63M 1,496.25M 1,694.24M 1,883.13M 1,857.08M
Operating cash flow 247.40M 207.22M 416.04M 321.12M 64.34M

Valuation Measures

Feb 2022
PER20.72
ROA5.66%
ROE9.35%
Operating margin5.13%
Profit margin3.09%

Key executives

  • President & Representative Director: Katsunori Sugiura
  • Manager-Corporate Planning Office: Makoto Kasai

Shareholders

  • SUGIURA FAMILY (33.1%)
  • Massachusetts Financial Services Co. (6.1%)
  • Baillie Gifford & Co. (6.1%)
  • Orbis Investment Management Ltd. (5.0%)
  • Sugi Holdings Co., Ltd. (3.0%)
  • SUGIURA KATSUNORI (2.9%)
  • SUGIURA SHINYA (2.9%)
  • MFS International (UK) Ltd. (2.3%)
  • Nomura Asset Management Co., Ltd. (2.2%)
  • TSURUHA Holdings, Inc. (2.0%)

Contact Details

Related Companies

  • Sugi Holdings Restricted Stock Compensation Plan
  • Watanabe Boeki KK
  • Sugi Medical Co. Ltd.
  • Sugi Pharmacy Co., Ltd.

Competitors

    Last Updated on 16 Aug, 2022

    Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

    Celebrate our next chapter
    Free access for everyone - Sep. 30

    Find out more